The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Robert R. Recker

Osteoporosis Research Center

Creighton University

601 N 30th Street #5766

Omaha

USA

[email]@creighton.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Osteoporosis Research Center, Creighton University, 601 N 30th Street #5766, Omaha, USA. 2002 - 2011
  • Creighton University School of Medicine, Creighton University, Omaha, Nebraska, USA. 2001 - 2010

References

  1. The effect of antiresorptives on bone quality. Recker, R.R., Armas, L. Clin. Orthop. Relat. Res. (2011) [Pubmed]
  2. Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study. Recker, R.R., Ste-Marie, L.G., Langdahl, B., Czerwinski, E., Bonvoisin, B., Masanauskaite, D., Rowell, L., Felsenberg, D. Bone (2010) [Pubmed]
  3. Oral ibandronate preserves trabecular microarchitecture: micro-computed tomography findings from the oral iBandronate Osteoporosis vertebral fracture trial in North America and Europe study. Recker, R.R., Ste-Marie, L.G., Langdahl, B., Masanauskaite, D., Ethgen, D., Delmas, P.D. J. Clin. Densitom (2009) [Pubmed]
  4. Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis. Recker, R.R., Marin, F., Ish-Shalom, S., Möricke, R., Hawkins, F., Kapetanos, G., de la Peña, M.P., Kekow, J., Farrerons, J., Sanz, B., Oertel, H., Stepan, J. J. Bone Miner. Res. (2009) [Pubmed]
  5. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. Recker, R.R., Delmas, P.D., Halse, J., Reid, I.R., Boonen, S., García-Hernandez, P.A., Supronik, J., Lewiecki, E.M., Ochoa, L., Miller, P., Hu, H., Mesenbrink, P., Hartl, F., Gasser, J., Eriksen, E.F. J. Bone Miner. Res. (2008) [Pubmed]
  6. Autosomal dominant high bone mass: the phenotype. A brief description. Recker, R.R. J. Musculoskelet. Neuronal. Interact (2008) [Pubmed]
  7. Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass. Recker, R.R., Kendler, D., Recknor, C.P., Rooney, T.W., Lewiecki, E.M., Utian, W.H., Cauley, J.A., Lorraine, J., Qu, Y., Kulkarni, P.M., Gaich, C.L., Wong, M., Plouffe, L., Stock, J.L. Bone (2007) [Pubmed]
  8. Skeletal fragility and bone quality. Recker, R.R. J. Musculoskelet. Neuronal. Interact (2007) [Pubmed]
  9. Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial. Recker, R., Lips, P., Felsenberg, D., Lippuner, K., Benhamou, L., Hawkins, F., Delmas, P.D., Rosen, C., Emkey, R., Salzmann, G., He, W., Santora, A.C. Curr. Med. Res. Opin (2006) [Pubmed]
  10. Risedronate for prevention and treatment of osteoporosis in postmenopausal women. Recker, R.R., Barger-Lux, J. Expert. Opin. Pharmacother (2005) [Pubmed]
  11. Trabecular bone microarchitecture after alendronate treatment of osteoporotic women. Recker, R., Masarachia, P., Santora, A., Howard, T., Chavassieux, P., Arlot, M., Rodan, G., Wehren, L., Kimmel, D. Curr. Med. Res. Opin (2005) [Pubmed]
  12. Summary--Novel therapies for osteoporosis. Recker, R.R. J. Musculoskelet. Neuronal. Interact (2005) [Pubmed]
  13. Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study. Recker, R.R., Weinstein, R.S., Chesnut, C.H., Schimmer, R.C., Mahoney, P., Hughes, C., Bonvoisin, B., Meunier, P.J. Osteoporos. Int (2004) [Pubmed]
  14. Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis. Recker, R., Stakkestad, J.A., Chesnut, C.H., Christiansen, C., Skag, A., Hoiseth, A., Ettinger, M., Mahoney, P., Schimmer, R.C., Delmas, P.D. Bone (2004) [Pubmed]
  15. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. Recker, R., Lappe, J., Davies, K.M., Heaney, R. J. Bone Miner. Res. (2004) [Pubmed]
  16. Genetic research in osteoporosis: Where are we? Where should we go next?. Recker, R.R. J. Musculoskelet. Neuronal. Interact (2004) [Pubmed]
  17. Transmenopausal and age-related changes in bone remodeling. Recker, R.R. J. Musculoskelet. Neuronal. Interact (2003) [Pubmed]
  18. Role of genetics in osteoporosis. Recker, R.R., Deng, H.W. Endocrine (2002) [Pubmed]
  19. Osteoporosis in women. Recker, R.R. J. Musculoskelet. Neuronal. Interact (2002) [Pubmed]
  20. The role of combination treatment for osteoporosis. Recker, R.R., Heaney, R.P. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
 
WikiGenes - Universities